Cidara Therapeutics Inc
F:20D
Cidara Therapeutics Inc
F:20D
Price:
9.56
EUR
Market Cap:
€866.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cidara Therapeutics Inc
F:20D
|
US |
Shareholder Yield
Current shareholder yield for 
20D is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
20D Price
Cidara Therapeutics Inc
Cidara Therapeutics Inc
Annual Price Range
9.56
52w Low
N/A
52w High
N/A
Price Metrics
| Average Annual Return | -36.32% |
| Standard Deviation of Annual Returns | 5.48% |
| Max Drawdown | -80% |
Shares Statistics
| Market Capitalization | 6.5B EUR |
| Shares Outstanding | 90 620 000 |
| Percentage of Shares Shorted |
N/A
|
20D Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
20D's latest stock split occurred on Apr 24, 2024
The company executed a 1-for-20 stock split, meaning that for every 20 shares held, investors received 1 new share.
Before the split, 20D traded at 9.56 per share. Afterward, the share price was about 9.56.
The adjusted shares began trading on Apr 24, 2024. This was the only stock split in 20D's history.
Pre-Split Price
9.56
9.56
Post-Split Price
9.56
Before
After
